HIGHLY ABSORPTIVE ORAL TYROSINE FORMULATION

Title:

HIGHLY ABSORPTIVE ORAL TYROSINE FORMULATION

Document Type and Number:

WIPO Patent Application WO/2019/059356

Kind Code:

A1

Abstract:

Provided is a tyrosine formulation having excellent bio-absorbability of tyrosine when orally ingested. This oral formulation contains glycyl tyrosine, a salt thereof, or a solvate thereof and has an improved bio-absorbability of tyrosine.

Inventors:

TAMURA KOTARO (JP)
IWASHITA MASAZUMI (JP)
MINEGISHI YOSHIHIKO (JP)

Application Number:

PCT/JP2018/035086

Publication Date:

March 28, 2019

Filing Date:

September 21, 2018

Export Citation:

Click for automatic bibliography generation Help

Assignee:

KAO CORP (JP)

International Classes:

A23L33/18; A61K38/05; A61P25/00; A61P43/00

Domestic Patent References:

WO2009038106A1	2009-03-26
WO2011078324A1	2011-06-30

Foreign References:

JP2003063959A	2003-03-05
JPH07149665A	1995-06-13

Other References:

ESAKI, K. ET AL.: "Increased Tyrosine in the Brain and Serum of Mice by Orally Administering Dipeptide SY", BIOSCI. BIOTECHNOL. BIOCHEM., vol. 77, no. 4, 2013, pages 847 - 849, XP055584370, ISSN: 0916-8451, DOI: 10.1271/bbb.120747
MAHER, T. J. ET AL.: "Use of Parenteral Dipeptides To Increase Serum Tyrosine Levels and To Enhance Catecholamine-Mediated Neurotransmission", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 79, no. 8, 1990, pages 685 - 687, XP055094176, ISSN: 0022-3549, DOI: doi:10.1002/jps.2600790807

Attorney, Agent or Firm:

THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: ELECTRIC ACTUATOR

Next Patent: COMPACT INCLUDING, AS CONSTITUENT, MOLDED ARTICLE FORMED OF SEMIAROMATIC POLYAMIDE RESIN COMPOSITION